CONFIDENTIAL CONSULTING AGREEMENTConfidential Consulting Agreement • May 8th, 2018 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Confidential Consulting Agreement (this “Agreement”) is executed as of the date shown on the signature page (the “Effective Date”), by and between FLG Partners, LLC, a California limited liability company (“FLG”), and Five Prime Therapeutics, Inc., a Delaware corporation (“Client”).
Consulting AgreementConsulting Agreement • May 8th, 2018 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”), effective as of April 7, 2018 (the “Effective Date”), is by and between Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”), and Marc Belsky, an individual (“Consultant”). FivePrime and Consultant may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
Amendment to Stock Option AgreementsStock Option Agreement • May 8th, 2018 • Five Prime Therapeutics Inc • Pharmaceutical preparations
This Amendment to Stock Option Agreements (this “Amendment”) is entered into between Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”), and Marc Belsky, an individual, effective as of April 6, 2018 (the “Amendment Effective Date”). Each capitalized term used but not defined in this Amendment has the meaning assigned to such term in the Stock Option Agreements (as defined below).
